
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.300 | 1.550 | 0.250 |
Shares | 98.700 | 98.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.737 | 18.184 |
Price to Book | 2.252 | 3.002 |
Price to Sales | 1.349 | 2.233 |
Price to Cash Flow | 9.059 | 11.946 |
Dividend Yield | 2.649 | 2.068 |
5 Years Earnings Growth | 8.773 | 9.864 |
Name | Net % | Category Average |
---|---|---|
Technology | 32.740 | 23.756 |
Healthcare | 17.160 | 12.614 |
Financial Services | 16.620 | 16.977 |
Consumer Cyclical | 9.510 | 10.474 |
Industrials | 7.530 | 11.969 |
Communication Services | 7.000 | 8.010 |
Consumer Defensive | 5.250 | 7.508 |
Energy | 2.110 | 3.367 |
Utilities | 0.940 | 2.545 |
Basic Materials | 0.890 | 3.970 |
Real Estate | 0.250 | 2.777 |
Number of long holdings: 199
Number of short holdings: 11
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 4.67 | 201.08 | +0.04% | |
NVIDIA | US67066G1040 | 4.32 | 157.75 | +1.76% | |
Microsoft | US5949181045 | 3.67 | 495.94 | -0.30% | |
Amazon.com | US0231351067 | 2.04 | 223.30 | +2.85% | |
Alphabet A | US02079K3059 | 1.95 | 178.53 | +2.88% | |
Meta Platforms | US30303M1027 | 1.25 | 733.63 | +1.04% | |
J&J | US4781601046 | 1.25 | 152.41 | +0.26% | |
Novartis | CH0012005267 | 1.23 | 96.18 | +0.17% | |
Progressive | US7433151039 | 1.18 | 263.99 | +0.91% | |
Merck&Co | US58933Y1055 | 1.10 | 79.10 | +0.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Rosenberg Global Equity Alpha FunAU | 738.4M | 3.21 | 11.99 | 8.55 | ||
Rosenberg US Equity Alpha Fund A US | 447.56M | 0.11 | 11.04 | 10.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review